BDO Wealth Advisors’s Axsome Therapeutics AXSM Stock Holding History

BDO Wealth Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$21.6K	Hold	300	–	–	﹤0.01%	564
2023 Q1	$18.5K	Hold	300	–	–	﹤0.01%	595
2022 Q4	$23.1K	Sell	300 -700	-70%	-$41.8K	﹤0.01%	549
2022 Q3	$45K	Sell	1,000 -1,000	-50%	-$50K	0.01%	419
2022 Q2	$77K	Sell	2,000 -500	-20%	-$15.8K	0.01%	358
2022 Q1	$103K	Hold	2,500	–	–	0.01%	334
2021 Q4	$94K	Hold	2,500	–	–	0.01%	360
2021 Q3	$82K	Hold	2,500	–	–	0.01%	380
2021 Q2	$169K	Hold	2,500	–	–	0.02%	310
2021 Q1	$142K	Hold	2,500	–	–	0.02%	325
2020 Q4	$204K	Hold	2,500	–	–	0.03%	232
2020 Q3	$178K	Hold	2,500	–	–	0.03%	230
2020 Q2	$206K	Hold	2,500	–	–	0.04%	215
2020 Q1	$147K	Buy	+2,500	New	+$204K	0.03%	235

Other funds holding AXSM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BDO Wealth Advisors's AXSM Position: Q2 2023 in Review

BDO Wealth Advisors held its Axsome Therapeutics (AXSM) position steady in Q2 2023 at 300 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

BDO Wealth Advisors first reported a position in AXSM in Q1 2020 and has held it in 14 quarters since. The position peaked at $206K in Q2 2020. 231 funds tracked by Wall St. Rank hold AXSM as of Q2 2023.

BDO Wealth Advisors held 300 shares of Axsome Therapeutics worth $21.6K as of Q2 2023.
BDO Wealth Advisors left its Axsome Therapeutics share count unchanged in Q2 2023.
Axsome Therapeutics made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #564 holding.
BDO Wealth Advisors first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 14 quarters since.
BDO Wealth Advisors's Axsome Therapeutics position peaked at $206K in Q2 2020.
231 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.